A vision for integrated publicly available information on regulated medical products
Clin Transl Sci
.
2022 Jun;15(6):1321-1327.
doi: 10.1111/cts.13275.
Epub 2022 Apr 9.
Authors
Khyati Roberts
1
,
Roopal Thakkar
1
,
Lina Aljuburi
2
,
Donna Boyce
3
,
Sean Curtis
4
,
Jennifer Dudinak
5
,
Helen Fitton
6
,
Carlos Garner
7
,
Michael Garvin
8
,
Susan Longman
9
,
Edward Reilly
2
,
Jordan Maitland
7
,
Alexis Reisin Miller
4
,
Muriel Pasté
6
,
Michelle Rohrer
10
,
Mark Taisey
11
,
Karin Van Baelen
12
,
Max Wegner
13
Affiliations
1
AbbVie, Chicago, Illinois, USA.
2
Sanofi, Paris, France.
3
Pfizer, New York, New York, USA.
4
Merck & Co., Inc., Kenilworth, New Jersey, USA.
5
Bristol Myers Squibb, New York, New York, USA.
6
GlaxoSmithKline, Brentford, UK.
7
Eli Lilly and Company, Indianapolis, Indiana, USA.
8
Astra Zeneca, Cambridge, UK.
9
Novartis, Basel, Switzerland.
10
Roche/Genentech, South San Francisco, California, USA.
11
Amgen, Thousand Oaks, California, USA.
12
Janssen, Beerse, Belgium.
13
Bayer, Leverkusen, Germany.
PMID:
35397194
PMCID:
PMC9199873
DOI:
10.1111/cts.13275
No abstract available